3rd Quarter - Report

NOVO NORDISK INC. for NOVO NORDISK INC.

Firm
Client
Income
—
Expenses
$910,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

S. 1002 SAFE DOSES Act (Modernizing criminal laws concerning theft of medical products)

Contacted: HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA)

Bills named: S. 1002 (112th)

Taxation/Internal Revenue Code TAX

H.R. 436 Protect Medical Innovation Act of 2011

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); SENATE; Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 436 (112th)

Copyright/Patent/Trademark CPT

H.R. 1249 and S. 23, America Invents Act

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1249 (112th), S. 23 (112th)

Health Issues HCR

Supporting increasing funding opportunities for better care and treatment of people with diabetes in P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically minority health, diabetes screening, National Diabetes Prevention Program, National Prevention Strategy, Medicaid Quality Measures, Medicare Annual Wellness Visit, ACOs (related to Medicare Share Savings Program), Coverage of Preventive Services under ACA, HHS Strategic Plan, HHS Multiple Chronic Conditions Framework, National Quality Strategy, Prevention and Public Health Fund, Diabetes Prevention Issues in a Survey of Primary Care Physicians, Adequate Inclusion of Diabetes Care In the Essential Health Benefits Package, IOM Committee on Valuing Community-based Non-Clinical Prevention Policies and Wellness Strategies, DOL Survey of Employer-Sponsored Health Insurance Coverage, CDC National Survey of Primary Care Policies for Managing Patients with Higher Blood Pressure, High Cholesterol, or Diabetes (NSPCP); H.R. 2954, the Health Equity and Accountability Act of 2011; HR 2960 National Diabetes Clinical Care Commission Act; S. 1559 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act FY2012

Contacted: Natl Institutes of Health (NIH); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); SENATE; Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 2954 (112th), H.R. 2960 (112th), S. 1559 (112th)

Medicare/Medicaid MMM

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010; Deficit reduction and debt ceiling negotiations: Issues related to Medicare Parts B & D, Medicaid rebates and the 340B program, CMS Proposed Coverage Decision Memorandum for Intensive Behavioral Therapy for Obesity

Contacted: Executive Office of the President (EOP); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Labor, Dept of (DOL)

Pharmacy PHA

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; prescription drug reimportation generally; Prescription Drug User Fee Act reauthorization

Contacted: Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Budget/Appropriations BUD

H.R. 1473 Department of Defense and Full Year Continuing Appropriations FY11; H.J. Res. 44, Further Continuing Appropriations FY11; H.J. Res. 48, Further Continuing Appropriations FY11; FY12 Budget Resolution: diabetes-related issues and issues related to modernizing cost estimates with respect to preventive health legislation

Contacted: SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH)

Bills named: H.J.Res. 48 (112th), H.R. 1473 (112th), H.J.Res. 44 (112th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
NOVO NORDISK FONDEN (FOUNDATION) Denmark Denmark 25.5% —
NOVO NORDISK A/S Denmark Denmark 100.0% —
NOVO A/S Denmark Denmark 25.5% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.